Organo Corporation (ORGJF) Comparison with companies in other sectors?

Organo Corporation has a share price of 45.97M. You can analyze Organo Corporation (ORGJF) competitors across different market sectors through stock heatmaps.

What are ORGJF's NET and operating margins?

Organo Corporation (ORGJF) operating margin is around 0.19, and net profit margin is approximately 0.15 as of the latest reports.

In what way does ORGJF's earnings per share (EPS) trend reflect its financial momentum?

Organo Corporation (ORGJF) EPS is 3.16 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Organo Corporation is 16.78, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Organo Corporation?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Organo Corporation like P/E which is 14.91, P/B which is 2.98, and PEG which is 0.007. Compare them with sector averages to evaluate if the stock is priced fairly.

Organo Corporation

ORGJF•PNK

Industrials

Industrial - Pollution & Treatment Controls

$53.03

$0.00(0.00%)

Organo Corporation (ORGJF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$3.16

P/E Ratio

16.78

ROE

0.22%

Net Margin

0.15%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$2.44B

Shares OutstandingTotal number of shares issued

$45.97M

Book Value/ShareNet worth per share

$2636.56

Revenue/ShareAnnual revenue per share

$3551.93

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$3.16

Net MarginNet income as percentage of revenue

14.79%

Operating MarginOperating income as percentage of revenue

19.06%

ROEReturn on shareholders' equity

21.90%

ROAReturn on total assets

12.42%

ROCEReturn on capital employed

23.94%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$364.42

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$145.36

Dividend YieldAnnual dividend as percentage of stock price

1.86%

Financial Ratios Analysis data is not available for ORGJFFinancial Ratios Analysis details for ORGJF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for ORGJFSector Benchmarking details for ORGJF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Organo Corporation Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Organo Corporation. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Organo Corporation's unique business strengths and challenges.

Key Financial Metrics for Organo Corporation

For Organo Corporation, essential financial indicators include EPS 3.16, PE 16.78, and ROE 0.22. These key ratios reveal insights into Organo Corporation's profitability, valuation, and operational health. Understanding these metrics enables you to compare Organo Corporation with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Organo Corporation

Metrics like Net Margin 14.79% and ROA 12.42% shed light on how well Organo Corporation is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Organo Corporation can sustain its operations and continue growing in the future.

Valuation and Market Position of Organo Corporation

Using ratios such as P/B Ratio 2.98 and PEG Ratio 0.007, investors can assess whether Organo Corporation is appropriately valued based on its financials and growth potential. These figures, combined with Organo Corporation's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Organo Corporation

Financial health indicators, such as Debt/Equity Ratio 0.19 and Cash Flow -, provide a snapshot of Organo Corporation's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Organo Corporation, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Organo Corporation

Investing in Organo Corporation based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Organo Corporation focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;